Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review

BACKGROUND: Prescribing pharmacologic therapies for critically ill patients requires a careful balancing of risks and benefits. Defining, monitoring, and reporting harms that occur in clinical trials conducted in critically ill populations, however, is challenging given that the natural history of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Moskowitz, Ari, Andersen, Lars W., Holmberg, Mathias J., Grossestreuer, Anne V., Berg, Katherine M., Granfeldt, Asger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346341/
https://www.ncbi.nlm.nih.gov/pubmed/32641148
http://dx.doi.org/10.1186/s13054-020-03113-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346341/
https://www.ncbi.nlm.nih.gov/pubmed/32641148
http://dx.doi.org/10.1186/s13054-020-03113-z

Ejemplares similares